Rohypnol is an intermediate-acting benzodiazepine with general properties similar to those of
Valium (diazepam). It is used in the short-term treatment of insomnia, as a pre-medication in
surgical procedures and for inducing anesthesia.

Like other benzodiazepines (such as Valium, Ativan and Xanax), Rohypnol’s therapeutic effects include:

sedation
muscle relaxation
reduction in anxiety
prevention of convulsions.
However, the sedative effects of Rohypnol are approximately 7 to 10 times stronger than
Valium. The action of Rohypnol appears 15 to 20 minutes after administration and last
approximately four to six hours. Some residual effects can be found 12 hours or more after
administration.

drowsiness, dizziness, loss of motor control, lack of coordination, slurred speech, confusion,
and gastrointestinal disturbances. Rohypnol can cause deep sedation, respiratory distress,
and blackouts that can last up to 24 hours.